Status:
UNKNOWN
Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins
Lead Sponsor:
University of Athens
Collaborating Sponsors:
Lito Maternity Hospital
Conditions:
Female Infertility
Eligibility:
FEMALE
20-50 years
Phase:
PHASE2
PHASE3
Brief Summary
Anti-Mullerian Hormone (AMH) is produced only in small ovarian follicles with quite stable levels during the cycle. There is not yet sufficient data to inform couples undergoing IVF about the effect o...
Detailed Description
Patients undergoing IVF will be included in the study. All patients will be counseled regarding their prognosis. Anti-Mullerian Hormone (AMH) will be measured prior to the initiation of IVF and during...
Eligibility Criteria
Inclusion
- All infertile women undergoing ovarian stimulation for IVF.
Exclusion
- Women who can not undergo IVF
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02237781
Start Date
October 1 2014
End Date
December 1 2015
Last Update
September 11 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.